Carmat Stock Fundamentals
| ALCAR Stock | EUR 0.97 0.03 3.00% |
Carmat fundamentals help investors to digest information that contributes to Carmat's financial success or failures. It also enables traders to predict the movement of Carmat Stock. The fundamental analysis module provides a way to measure Carmat's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Carmat stock.
Carmat |
Carmat Company Shares Outstanding Analysis
Carmat's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Carmat Shares Outstanding | 22.67 M |
Most of Carmat's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Carmat is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Carmat has 22.67 M of shares currently outstending. This is 87.44% lower than that of the Health Care Equipment & Supplies sector and 73.61% lower than that of the Health Care industry. The shares outstanding for all France stocks is 96.04% higher than that of the company.
Carmat Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Carmat's current stock value. Our valuation model uses many indicators to compare Carmat value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Carmat competition to find correlations between indicators driving Carmat's intrinsic value. More Info.Carmat is rated fifth in return on equity category among its peers. It is rated fourth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Carmat's earnings, one of the primary drivers of an investment's value.Carmat Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Carmat's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Carmat could also be used in its relative valuation, which is a method of valuing Carmat by comparing valuation metrics of similar companies.Carmat is currently under evaluation in shares outstanding category among its peers.
Carmat Fundamentals
| Return On Equity | -2.54 | |||
| Return On Asset | -0.39 | |||
| Operating Margin | (21.94) % | |||
| Current Valuation | 218.78 M | |||
| Shares Outstanding | 22.67 M | |||
| Shares Owned By Insiders | 42.90 % | |||
| Shares Owned By Institutions | 2.28 % | |||
| Price To Earning | (6.35) X | |||
| Price To Book | 1,235 X | |||
| Price To Sales | 87.71 X | |||
| Revenue | 2.34 M | |||
| Gross Profit | (37.45 M) | |||
| EBITDA | (51.98 M) | |||
| Net Income | (61.87 M) | |||
| Cash And Equivalents | 25.3 M | |||
| Cash Per Share | 2.73 X | |||
| Total Debt | 52.02 M | |||
| Debt To Equity | 22.60 % | |||
| Current Ratio | 2.71 X | |||
| Book Value Per Share | 0.06 X | |||
| Cash Flow From Operations | (60.17 M) | |||
| Earnings Per Share | (3.54) X | |||
| Target Price | 28.6 | |||
| Number Of Employees | 171 | |||
| Beta | 0.94 | |||
| Market Capitalization | 210.79 M | |||
| Total Asset | 69.08 M | |||
| Retained Earnings | (94 M) | |||
| Working Capital | 2 M | |||
| Current Asset | 7 M | |||
| Current Liabilities | 5 M | |||
| Z Score | 1.0 | |||
| Net Asset | 69.08 M |
About Carmat Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Carmat's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Carmat using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Carmat based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. The company was founded in 2008 and is based in Vlizy-Villacoublay, France. CARMAT operates under Medical Instruments Supplies classification in France and is traded on Paris Stock Exchange. It employs 81 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Carmat Stock Analysis
When running Carmat's price analysis, check to measure Carmat's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Carmat is operating at the current time. Most of Carmat's value examination focuses on studying past and present price action to predict the probability of Carmat's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Carmat's price. Additionally, you may evaluate how the addition of Carmat to your portfolios can decrease your overall portfolio volatility.